Did you know that psychedelics are a popular clinical treatment used in Arizona hospitals and emergency rooms?
While stigma still exists, medical experts have studies showing proven benefits for both mental and physical health, including studies from John Hopkins. The national market is currently at $6.8 billion but is expected to grow to $69 billion by 2027.
At Daytryp Health, we have a team of medical professionals and experts and clinically use ketamine to treat mental health ailments such as PTSD, anxiety and depression, as well as physical ailments. There are many psychedelics used throughout history, but these are the most commonly researched and where they stand in Arizona.
Commonly referred to as ‘magic mushrooms,’ this type of psychedelic medicine grows naturally in several regions of the United States and abroad. Psilocybin has been used ceremonially and therapeutically for hundreds if not thousands of years. Recent research shows there are plenty of psychiatric, mental and physical benefits, which has led to legalization for clinical usage in states such as Oregon, Colorado, and parts of Michigan, to name a few.
Although it’s currently illegal to harvest or use psilocybin for clinical use in Arizona, there is a state bill coming through to push for further clinical research.
MDMA (also known as molly or ecstasy) is illegal in every state in the United States. However, there are numerous studies showing promising clinical usage. Before 1985, psychologists touted the benefits when MDMA was used in talk therapy sessions and this psychedelic is suspected to be extremely useful for the treatment of PTSD.
In 2022, the FDA granted access to MDMA for assisted therapy for patients only in a clinical setting. It’s currently being studied in clinical trials across the states. There is currently a push for the legalization of MDMA for therapeutic usage and experts believe the platform for usage will come in 2024. Just recently, Australia legalized MDMA and all psychedelics for therapeutic use.
Ketamine is FDA- approved for clinical usage since the 1970s. This dissociative anesthetic and analgesic was again approved by the FDA for psychiatric use in 2019, including a nasal spray for depression, and is one of the most commonly researched psychedelics in America.
Ketamine’s neurobiological mechanisms are unique as the psychedelic can change patient perspective on a situation by working with neurotransmitters and NMDA receptors. In 2019, Stanford University released a study on the transformative power of ketamine for severe depression and says it’s a great option for treatment resistant patients.
Our medical experts advise clinical treatment of ketamine be used in a professional setting and not as home, though the option is growing for clinical home usage. A journey guide should always be present for the process and include intake procedures.
Daytryp Health offers ketamine treatments in a relaxed, non-clinical setting with medical professionals. We also offer the “Heroes Program” for military, first responders, frontline healthcare works, correctional officers, 911 dispatchers and teachers which offers a 15% discount. Furthermore, we allot a full scholarship monthly for a package of 3 KAP sessions to those who qualify and can’t afford the treatment. Details on that can be found on our website under Heroes Program.
Visit our website, daytryp.com to learn more about our psychedelic wellness facility in the Arcadia area of Phoenix. Fill out the application to see if you’re eligible for a scholarship that includes three free treatments.
Author: Chris Cohn is the founder of Daytryp Health with a heavy medical background.